Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Temporal trends of inpatient C. difficile infections within the Veterans Health Administration hospitals: An analysis of the effect of molecular testing, time to testing, and mandatory reporting.

Sumon ZE, Lesse AJ, Sellick JA, Tetewsky S, Mergenhagen KA.

Infect Control Hosp Epidemiol. 2019 Nov 11:1-8. doi: 10.1017/ice.2019.281. [Epub ahead of print]

PMID:
31708000
2.

Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship.

Mergenhagen KA, Starr KE, Wattengel BA, Lesse AJ, Sumon Z, Sellick JA.

Clin Infect Dis. 2019 Oct 1. pii: ciz974. doi: 10.1093/cid/ciz974. [Epub ahead of print]

PMID:
31573026
3.

A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).

Shafiq I, Bulman ZP, Spitznogle SL, Osorio JE, Reilly IS, Lesse AJ, Parameswaran GI, Mergenhagen KA, Tsuji BT.

Infect Dis (Lond). 2017 May;49(5):410-416. doi: 10.1080/23744235.2016.1277587. Epub 2017 Jan 24.

PMID:
28116950
4.

An Outbreak of Severe Group A Streptococcus Infections Associated with Podiatric Application of a Biologic Dermal Substitute.

Ibrahim LA, Sellick JA, Watson EL, McCabe LM, Schoenhals KA, Martinello RA, Lesse AJ.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):306-12. doi: 10.1017/ice.2015.306. Epub 2015 Dec 17.

PMID:
26673775
5.

Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics.

Tsuji BT, Harigaya Y, Lesse AJ, Forrest A, Ngo D.

J Chemother. 2013 Feb;25(1):32-5. doi: 10.1179/1973947812Y.0000000060.

6.
7.

A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease.

Murphy TF, Lesse AJ, Kirkham C, Zhong H, Sethi S, Munson RS Jr.

PLoS One. 2011;6(10):e25923. doi: 10.1371/journal.pone.0025923. Epub 2011 Oct 5.

8.

USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?

Kreisel KM, Stine OC, Johnson JK, Perencevich EN, Shardell MD, Lesse AJ, Gordin FM, Climo MW, Roghmann MC.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):285-90. doi: 10.1016/j.diagmicrobio.2011.03.010. Epub 2011 May 10.

9.

Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.

Almyroudis NG, Lesse AJ, Hahn T, Samonis G, Hazamy PA, Wongkittiroch K, Wang ES, McCarthy PL Jr, Wetzler M, Segal BH.

Infect Control Hosp Epidemiol. 2011 May;32(5):490-6. doi: 10.1086/659408.

PMID:
21515980
10.

Genomic comparisons of USA300 Staphylococcus aureus colonizating the nose and rectum of children with skin abscesses.

Lemmens N, van Wamel W, Snijders S, Lesse AJ, Faden H, van Belkum A.

Microb Pathog. 2011 Mar-Apr;50(3-4):192-9. doi: 10.1016/j.micpath.2010.12.006. Epub 2010 Dec 21.

PMID:
21172415
11.

Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia.

Kreisel KM, Johnson JK, Stine OC, Shardell MD, Perencevich EN, Lesse AJ, Gordin FM, Climo MW, Roghmann MC.

Emerg Infect Dis. 2010 Sep;16(9):1419-27. doi: 10.3201/eid1609.091802.

12.
13.

Importance of colonization site in the current epidemic of staphylococcal skin abscesses.

Faden H, Lesse AJ, Trask J, Hill JA, Hess DJ, Dryja D, Lee YH.

Pediatrics. 2010 Mar;125(3):e618-24. doi: 10.1542/peds.2009-1523. Epub 2010 Feb 15.

PMID:
20156893
14.

Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia.

Harigaya Y, Bulitta JB, Forrest A, Sakoulas G, Lesse AJ, Mylotte JM, Tsuji BT.

Antimicrob Agents Chemother. 2009 Sep;53(9):3894-901. doi: 10.1128/AAC.01585-08. Epub 2009 Jul 13.

15.

Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density.

Tsuji BT, Harigaya Y, Lesse AJ, Sakoulas G, Mylotte JM.

Diagn Microbiol Infect Dis. 2009 Jun;64(2):220-4. doi: 10.1016/j.diagmicrobio.2009.01.028. Epub 2009 Apr 2.

PMID:
19345040
16.
17.

Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.

Ruckdeschel EA, Kirkham C, Lesse AJ, Hu Z, Murphy TF.

Infect Immun. 2008 Apr;76(4):1599-607. doi: 10.1128/IAI.01253-07. Epub 2008 Jan 28.

18.

Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.

Lesse AJ, Mylotte JM.

Am J Infect Control. 2006 Dec;34(10):642-50.

PMID:
17161739
19.

Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae.

Murphy TF, Brauer AL, Sethi S, Kilian M, Cai X, Lesse AJ.

J Infect Dis. 2007 Jan 1;195(1):81-9. Epub 2006 Nov 27.

PMID:
17152011
20.

Characterization of igaB, a second immunoglobulin A1 protease gene in nontypeable Haemophilus influenzae.

Fernaays MM, Lesse AJ, Cai X, Murphy TF.

Infect Immun. 2006 Oct;74(10):5860-70.

22.
23.

Expression of a peroxiredoxin-glutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection.

Murphy TF, Kirkham C, Sethi S, Lesse AJ.

FEMS Immunol Med Microbiol. 2005 Apr 1;44(1):81-9.

24.

Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis.

Adlowitz DG, Hiltke T, Lesse AJ, Murphy TF.

Vaccine. 2004 Jun 30;22(20):2533-40.

PMID:
15193378
25.

Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Johnson JR, Gajewski A, Lesse AJ, Russo TA.

J Clin Microbiol. 2003 Dec;41(12):5798-802.

26.
28.
29.

Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus.

Inzana TJ, Hensley J, McQuiston J, Lesse AJ, Campagnari AA, Boyle SM, Apicella MA.

Infect Immun. 1997 Nov;65(11):4675-81. Erratum in: Infect Immun 1998 Aug;66(8):4010.

31.
32.

Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis.

Campagnari AA, Karalus R, Apicella M, Melaugh W, Lesse AJ, Gibson BW.

Infect Immun. 1994 Jun;62(6):2379-86.

34.
35.

Pathophysiology of blood-brain barrier alterations during experimental Haemophilus influenzae meningitis.

Tunkel AR, Wispelwey B, Quagliarello VJ, Rosser SW, Lesse AJ, Hansen EJ, Scheld WM.

J Infect Dis. 1992 Jun;165 Suppl 1:S119-20. No abstract available.

PMID:
1588144
36.
38.

Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.

Campagnari AA, Spinola SM, Lesse AJ, Kwaik YA, Mandrell RE, Apicella MA.

Microb Pathog. 1990 May;8(5):353-62.

PMID:
1699109
39.

In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.

Mandrell RE, Lesse AJ, Sugai JV, Shero M, Griffiss JM, Cole JA, Parsons NJ, Smith H, Morse SA, Apicella MA.

J Exp Med. 1990 May 1;171(5):1649-64.

40.

Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Lesse AJ, Campagnari AA, Bittner WE, Apicella MA.

J Immunol Methods. 1990 Jan 24;126(1):109-17.

PMID:
2106001
41.
43.

Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.

Lesse AJ, Freer C, Salata RA, Francis JB, Scheld WM.

Am J Med. 1987 Apr 27;82(4A):247-53.

PMID:
3555043

Supplemental Content

Loading ...
Support Center